Pharmacokinetics and safety of ceftiofur crystalline free acid in New Zealand White rabbits (Oryctolagus cuniculus).

OBJECTIVE To determine the pharmacokinetics and adverse effects following SC administration of ceftiofur crystalline free acid (CCFA) in New Zealand White rabbits. ANIMALS 6 adult sexually intact female New Zealand White rabbits. PROCEDURES Each rabbit was administered 40 mg of CCFA/kg SC. A blood sample was obtained immediately before (0 minutes), at 5 and 30 minutes after, and at 1, 1.5, 2, 3, 4, 8, 12, 24, 48, 72, 95, 120, 144, and 168 hours after administration, and plasma concentrations of ceftiofur free acid equivalents (CFAE) were measured. Pharmacokinetic parameters were calculated. For each rabbit, body weight, food consumption, fecal output, and injection site were monitored. Minimum inhibitory concentrations of ceftiofur for 293 bacterial isolates from rabbit clinical samples were determined. RESULTS Mean ± SD peak plasma concentration of CFAE and time to maximum plasma concentration were 33.13 ± 10.15 μg/mL and 1.75 ± 0.42 hours, respectively. The mean terminal half-life of CFAE was 42.6 ± 5.2 hours. Plasma CFAE concentration was > 4 μg/mL for approximately 24 hours and > 1 μg/mL for at least 72 hours after CCFA administration. An apparently nonpainful subcutaneous nodule developed at the injection site in 3 of 6 rabbits. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that CCFA (40 mg/kg) could be administered SC every 24 to 72 hours to New Zealand White rabbits to treat infections with ceftiofur-susceptible bacteria. Single-dose administration of CCFA resulted in minimal adverse effects. Additional studies are needed to evaluate the effects of repeated CCFA administration in New Zealand White rabbits.

[1]  L. Tell,et al.  Pharmacokinetics of a single intramuscular injection of ceftiofur crystalline-free acid in American black ducks (Anas rubripes). , 2012, American journal of veterinary research.

[2]  R Czerniak,et al.  Gender-Based Differences in Pharmacokinetics in Laboratory Animal Models , 2001, International journal of toxicology.

[3]  H. Derendorf,et al.  Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. , 2002, International journal of antimicrobial agents.

[4]  Brooks Dl,et al.  Pharmacokinetic properties of enrofloxacin in rabbits. , 1991 .

[5]  W. Van Bonn,et al.  Pharmacokinetics of ceftiofur crystalline-free acid (EXCEDE sterile suspension) administered via intramuscular injection in wild California sea lions (Zalophus californianus). , 2013, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[6]  E. Goldstein,et al.  Periodontal Bacteria in Rabbit Mandibular and Maxillary Abscesses , 2002, Journal of Clinical Microbiology.

[7]  O. Ladefoged.  Pharmacokinetics of trimethoprim (TMP) in normal and febrile rabbits. , 2009, Acta pharmacologica et toxicologica.

[8]  L. Tell,et al.  Pharmacokinetics of ceftiofur crystalline free acid after single subcutaneous administration in lactating and nonlactating domestic goats (Capra aegagrus hircus). , 2011, Journal of veterinary pharmacology and therapeutics.

[9]  R. P. Hunter,et al.  Concepts and Issues with Interspecies Scaling in Zoological Pharmacology , 2008, Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.

[10]  S. A. Brown,et al.  Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equine. , 2011, Journal of veterinary pharmacology and therapeutics.

[11]  K. Wasan,et al.  Blood and plasma lipoprotein distribution and gender differences in the plasma pharmacokinetics of lipid-associated annamycin. , 1997, Pharmacology & toxicology.

[12]  S. Croubels,et al.  High-performance liquid chromatographic-UV detection analysis of ceftiofur and its active metabolite desfuroylceftiofur in horse plasma and synovial fluid after regional intravenous perfusion and systemic intravenous injection of ceftiofur sodium , 2004 .

[13]  S. Cox,et al.  Pharmacokinetics of long-acting ceftiofur crystalline-free acid in helmeted guineafowl (Numida meleagris) after a single intramuscular injection. , 2011, American journal of veterinary research.

[14]  J. Paul-Murphy.  Critical care of the rabbit. , 2007, The veterinary clinics of North America. Exotic animal practice.

[15]  M. Ghannoum,et al.  Effect of Parenteral Antibiotic Administration on Establishment of Intestinal Colonization by Candida glabrata in Adult Mice , 2005, Antimicrobial Agents and Chemotherapy.

[16]  Gerard D. Wright,et al.  Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. , 2013, International journal of medical microbiology : IJMM.

[17]  R. Junge,et al.  Pharmacokinetics of a long-acting ceftiofur crystalline-free acid formulation in Asian elephants (Elephas maximus). , 2012, American journal of veterinary research.

[18]  L. Tell,et al.  Pharmacokinetics of ceftiofur crystalline free acid after single and multiple subcutaneous administrations in healthy alpacas (Vicugna pacos). , 2013, Journal of veterinary pharmacology and therapeutics.

[19]  Chad B. Sandusky,et al.  Laboratory routines cause animal stress. , 2004, Contemporary topics in laboratory animal science.

[20]  G. Pérez-Martínez,et al.  Characterization of faecal enterococci from rabbits for the selection of probiotic strains , 2004, Journal of applied microbiology.

[21]  L. Trepanier.  Applying pharmacokinetics to veterinary clinical practice. , 2013, The Veterinary clinics of North America. Small animal practice.

[22]  L. Tell,et al.  Pharmacokinetics of ceftiofur crystalline-free acid following subcutaneous administration of a single dose to sheep. , 2014, American journal of veterinary research.

[23]  L. Tell,et al.  Pharmacokinetics of ceftiofur sodium and ceftiofur crystalline free acid in neonatal foals. , 2011, Journal of veterinary pharmacology and therapeutics.